S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024 · Transaction May 8, 2024 · Filed Aug 5, 2026 · $1,001 to $15,000
ARCX · XBI
+3.00% · +$4.48 · Vol 12.1M
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
XBI
State Street SPDR S&P Biotech ETF
$153.77
Follow $XBI
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $XBI by emailVeridion Score
BETAFund score · valuation-exemptMEDIUM CONF · 4 of 5 factors measuredFri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET · XBI
MethodologyFund Flow absence reason unknown
XBI
State Street SPDR S&P Biotech ETF
Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Fund-class market intelligence score across five applicable factors. Company valuation and earnings inputs are excluded.
48/ 100
Veridion Score
Middle range · MEDIUM confidence · 4 of 5 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Momentum · attention · fund flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 4 of 5 factors measured · Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is XBI moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About State Street SPDR S&P Biotech ETF
Listed since
2006
Country
US
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$149.32
Day high
$154.50
Day low
$149.03
Previous close
$149.29
52W high
$169.55
-9.31% from high
52W low
$104.99
76% of range
Beta
0.79
Shares out
65.3M
Volume
12.1M
1.33× rel vol
Avg volume
9.1M
VWAP
$152.98
Price history computed in-house
1W
-0.43%
1M
-1.94%
3M
-3.31%
1Y
+46.46%
YTD
+26.11%
SMA 50 $158.26 · below
SMA 200 $139.57 · above
52W position 76%
XBI overview
Related filings and maps
Financials
Company financial statements are not applicable for XBI.
Public disclosures
Congress activity in XBI
4 filers · 6 buys · 2 sells (1 labeled S (partial)) · Oct 2, 2015 to May 8, 2024 · House 3 / Senate 5
All available history · Latest 5 of 8 lines · Read 2026-10-10T09:07:17.085Z
Official filing ↗
David P. JoyceSell
SPDR Series Trust SPDR S&P Biotech ETF · Transaction Jun 30, 2023 · Filed Aug 6, 2024 · $15,001 to $50,000
SPDR S&P Biotech ETF · Transaction Mar 9, 2018 · Filed Mar 12, 2018 · $1,001 to $15,000
SPDR S&P Biotech ETF · Transaction Jun 19, 2017 · Filed Jun 20, 2017 · $1,001 to $15,000
SPDR S&P Biotech ETF · Transaction Mar 6, 2017 · Filed Mar 7, 2017 · $1,001 to $15,000
Federal contracts
XBI contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for XBI in this window.
Lobbying spend
XBI lobbying filings, year to date.
Registered lobbying filings matched to State Street SPDR S&P Biotech ETF.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for XBI in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for XBI.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.